[Chemotherapeutic effectiveness of erythromycin, rifampicin and tetracyclines in chlamydiosis and mycoplasmosis in children].
The data on the incidence of Chlamydia and Mycoplasma infections in children with inflammatory diseases of the respiration organs are presented. The peculiarities of the clinical manifestations and the attempts to carry out the clinical differential diagnostication are described. The chemotherapeutic efficacies of erythromycin, rifampicin and tetracycline in the treatment of pneumonia due to Chlamydia and Mycoplasma in children were studied. There was observed similarity in the clinical signs of the infections. The differential diagnostication without the data on the disease etiology was shown impossible. Marked chemotherapeutic efficacies of erythromycin and rifampicin in the treatment of chlamydiosis and mycoplasmosis in infants were stated. The tetracyclines were found to be efficient in the treatment of older children.
Vasilos
L V
LV
Rumel'
N B
NB
Shchuka
S S
SS
D017677:Age Distribution; D002675:Child, Preschool; D002690:Chlamydia Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D002692:Chlamydia trachomatis; D003937:Diagnosis, Differential; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D011019:Pneumonia, Mycoplasma / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D012140:Respiratory Tract Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D012293:Rifampin / Q000627:therapeutic use*; D013754:Tetracyclines / Q000627:therapeutic use*
D013754:Tetracyclines; D004917:Erythromycin; D012293:Rifampin